BlackRock’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,597,418
Closed -$26.1M 5561
2024
Q4
$26.1M Sell
8,597,418
-130,166
-1% -$567K ﹤0.01% 2873
2024
Q3
$45.3M Buy
8,727,584
+162,267
+2% +$806K ﹤0.01% 2526
2024
Q2
$22M Buy
8,565,317
+1,252,838
+17% +$4.28M ﹤0.01% 2930
2024
Q1
$36M Sell
7,312,479
-140,892
-2% -$834K ﹤0.01% 2645
2023
Q4
$65.5M Buy
7,453,371
+696,651
+10% +$5.71M ﹤0.01% 2316
2023
Q3
$77.5M Buy
6,756,720
+230,132
+4% +$4.42M ﹤0.01% 2137
2023
Q2
$165M Buy
6,526,588
+387,524
+6% +$12.1M ﹤0.01% 1713
2023
Q1
$198M Sell
6,139,064
-934,799
-13% -$29.1M 0.01% 1544
2022
Q4
$131M Buy
7,073,863
+942,047
+15% +$21.5M ﹤0.01% 1835
2022
Q3
$166M Buy
6,131,816
+446,985
+8% +$9.07M 0.01% 1624
2022
Q2
$78.6M Buy
5,684,831
+397,683
+8% +$6.12M ﹤0.01% 2186
2022
Q1
$103M Sell
5,287,148
-46,951
-0.9% -$712K ﹤0.01% 2123
2021
Q4
$87.1M Sell
5,334,099
-37,368
-0.7% -$623K ﹤0.01% 2297
2021
Q3
$150M Buy
5,371,467
+23,789
+0.4% +$679K ﹤0.01% 1937
2021
Q2
$159M Sell
5,347,678
-46,161
-0.9% -$1.33M ﹤0.01% 1956
2021
Q1
$151M Buy
5,393,839
+381,487
+8% +$10.6M ﹤0.01% 1915
2020
Q4
$142M Buy
5,012,352
+131,164
+3% +$3.4M ﹤0.01% 1848
2020
Q3
$123M Buy
4,881,188
+441,988
+10% +$11.6M ﹤0.01% 1756
2020
Q2
$108M Buy
4,439,200
+431,821
+11% +$8.52M ﹤0.01% 1791
2020
Q1
$59.3M Buy
4,007,379
+318,722
+9% +$6.59M ﹤0.01% 1959
2019
Q4
$59.9M Buy
3,688,657
+122,686
+3% +$1.9M ﹤0.01% 2246
2019
Q3
$46.4M Buy
3,565,971
+37,912
+1% +$464K ﹤0.01% 2337
2019
Q2
$45.8M Sell
3,528,059
-22,079
-0.6% -$278K ﹤0.01% 2369
2019
Q1
$56M Buy
3,550,138
+343,538
+11% +$5.96M ﹤0.01% 2209
2018
Q4
$64.5M Buy
3,206,600
+11,617
+0.4% +$256K ﹤0.01% 2080
2018
Q3
$79.4M Buy
3,194,983
+263,003
+9% +$7.15M ﹤0.01% 2117
2018
Q2
$80.5M Buy
2,931,980
+521,536
+22% +$15.7M ﹤0.01% 2078
2018
Q1
$74.2M Buy
2,410,444
+242,233
+11% +$7.79M ﹤0.01% 2031
2017
Q4
$77.5M Buy
2,168,211
+2,611
+0.1% +$75K ﹤0.01% 2019
2017
Q3
$59.7M Buy
2,165,600
+12,477
+0.6% +$302K ﹤0.01% 2179
2017
Q2
$56.8M Buy
2,153,123
+105,069
+5% +$2.34M ﹤0.01% 2160
2017
Q1
$42.6M Buy
2,048,054
+2,046,647
+145,462% +$42M ﹤0.01% 2323
2016
Q4
$30K Sell
1,407
-217
-13% -$3.63K ﹤0.01% 3136
2016
Q3
$26K Sell
1,624
-269
-14% -$3.91K ﹤0.01% 3221
2016
Q2
$26K Buy
1,893
+423
+29% +$7.48K ﹤0.01% 3196
2016
Q1
$25K Buy
1,470
+1,102
+299% +$22.4K ﹤0.01% 2747
2015
Q4
$13K Hold
368
﹤0.01% 2774
2015
Q3
$11K Hold
368
﹤0.01% 2697
2015
Q2
$12K Buy
368
+103
+39% +$2.65K ﹤0.01% 2691
2015
Q1
$5K Hold
265
﹤0.01% 3035
2014
Q4
$4K Buy
265
+89
+51% +$1.55K ﹤0.01% 3109
2014
Q3
$3K Hold
176
﹤0.01% 3155
2014
Q2
$6K Buy
+176
New +$5.51K ﹤0.01% 3081

Other funds holding RVNC